Product Images Acebutolol Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Acebutolol Hydrochloride NDC 10135-631 by Marlex Pharmaceuticals Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

The following structural formula for Acebutolol HCl, USP is a selective, hydrophilic beta-adrenoreceptor blocking agent with mild intrinsic sympathomimetic activity for use in treating patients with hypertension and ventricular arrhythmias. It is marketed in capsule form for oral administration. Acebutolol HCl capsules, USP are provided in two dosage strengths which contain 200 mg or 400 mg of acebutolol as the hydrochloride salt. The inactive ingredients present are D&C Red 28, D&C Yellow 10, FD&C Blue 1, FD&C Red 40, gelatin, maize starch, povidone, stearic acid and titanium dioxide. - acebutolol hydrochloride capsules 01

The following structural formula for Acebutolol HCl, USP is a selective, hydrophilic beta-adrenoreceptor blocking agent with mild intrinsic sympathomimetic activity for use in treating patients with hypertension and ventricular arrhythmias. It is marketed in capsule form for oral administration. Acebutolol HCl capsules, USP are provided in two dosage strengths which contain 200 mg or 400 mg of acebutolol as the hydrochloride salt. The inactive ingredients present are D&C Red 28, D&C Yellow 10, FD&C Blue 1, FD&C Red 40, gelatin, maize starch, povidone, stearic acid and titanium dioxide. - acebutolol hydrochloride capsules 01

The following table shows the frequency of treatment-related side effects derived from controlled clinical trials in patients with hypertension, angina pectoris, and arrhythmia. These patients received acebutolol, propranolol, or hydrochlorothiazide as monotherapy, or placebo. - acebutolol hydrochloride capsules 02

The following table shows the frequency of treatment-related side effects derived from controlled clinical trials in patients with hypertension, angina pectoris, and arrhythmia. These patients received acebutolol, propranolol, or hydrochlorothiazide as monotherapy, or placebo. - acebutolol hydrochloride capsules 02

The incidence of drug-related adverse effects (volunteered and solicited) according to acebutolol dose is shown below. (Data from 266 hypertensive patients treated for 3 months on a constant dose.) - acebutolol hydrochloride capsules 03

The incidence of drug-related adverse effects (volunteered and solicited) according to acebutolol dose is shown below. (Data from 266 hypertensive patients treated for 3 months on a constant dose.) - acebutolol hydrochloride capsules 03

PRINCIPAL DISPLAY PANELNDC 10135-0630-01Acebutolol HydrochlorideCapsules, USP200 mg100 CAPSULESRx Only - acebutolol hydrochloride capsules 04

PRINCIPAL DISPLAY PANELNDC 10135-0630-01Acebutolol HydrochlorideCapsules, USP200 mg100 CAPSULESRx Only - acebutolol hydrochloride capsules 04

PRINCIPAL DISPLAY PANELNDC 10135-0631-01Acebutolol HydrochlorideCapsules, USP400 mg100 CAPSULESRx Only - acebutolol hydrochloride capsules 05

PRINCIPAL DISPLAY PANELNDC 10135-0631-01Acebutolol HydrochlorideCapsules, USP400 mg100 CAPSULESRx Only - acebutolol hydrochloride capsules 05

This is a description of a medication labeled as NDC 10135-0631-01. Each capsule contains Acebutolol hydrochloride USP, which is equivalent to 400 mg of acebutolol. The manufacturer is Marlex Pharmaceuticals, Inc. The medication is for adult use only with the dosage specified in the package insert. It is important to keep this medication and all drugs out of the reach of children in a tightly closed, light-resistant container. It should be stored at 20° to 25°C (68° to 77°F) and protected from light. This medication should be given upon prescription only.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.